FDA NDC Directory · JSON-LD · Markdown

Xolair

NDC 50242-227 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameomalizumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA103976
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsOMALIZUMAB (300 mg/2mL)
Marketing started20230818
Package count4

External sources

Source: openFDA. Public-domain (CC0).